Indegene announces the amalgamation of its two step-down subsidiaries, Indegene Aptilon Services, Inc. and Trilogy Writing & Consulting Inc., effective January 01, 2026. The new entity will be known as Indegene Healthcare Canada Inc. This restructuring aims to streamline operations. Projected revenue for Indegene Aptilon Services is CAD 1,375,000, and for Trilogy Writing & Consulting Inc. is CAD 5,400,000.
Subsidiary Restructuring
Indegene has announced the amalgamation of two of its step-down subsidiaries to form a single entity. Effective January 01, 2026, Indegene Aptilon Services, Inc. and Trilogy Writing & Consulting Inc. have combined to create Indegene Healthcare Canada Inc.
Entities Involved
Indegene Aptilon Services, Inc., along with Trilogy Writing & Consulting Inc. (formerly known as Trilogy Writing and Consulting ULC (Canada)), are both 100% held by Indegene, Inc. USA, a wholly-owned subsidiary of Indegene Limited.
Projected Revenue
The combined entity brings together significant projected revenue streams. Indegene Aptilon Services, Inc. is projected to generate CAD 1,375,000, while Trilogy Writing & Consulting Inc. is expected to contribute CAD 5,400,000 in revenue for FY25-26.
Business Focus
Trilogy specializes in medical writing and regulatory documentation services for the pharmaceutical and life science industries. Indegene focuses on digital-first life-sciences commercialization, providing technology-enabled services.
Rationale
The amalgamation is part of an internal restructuring process to streamline operations.
Source: BSE
